Literature DB >> 10438441

A Danish national cohort of 730 infants born after intracytoplasmic sperm injection (ICSI) 1994-1997.

A Loft1, K Petersen, K Erb, A L Mikkelsen, J Grinsted, F Hald, J Hindkjaer, K M Nielsen, P Lundstrom, A Gabrielsen, S Lenz, P Hornnes, S Ziebe, H B Ejdrup, A Lindhard, Y Zhou, A Nyboe Andersen.   

Abstract

This national cohort study included all clinical pregnancies obtained after intracytoplasmic sperm injection (ICSI) registered in Denmark between January 1994 and July 1997 at five public and eight private fertility clinics. Laboratory and clinical data were obtained from the fertility clinics. The couples answered a questionnaire regarding the pregnancy and the health of the child (response rate 94%). Data validation was carried out through discharge charts. The mean age of the women was 32.1 years. In 84.2% of couples, male factor was the main reason for performing ICSI, and in 4.8% epididymal spermatozoa were used. The mean number of embryos replaced was 2.3 (range 1-3) and in 95% of cases fresh embryos were transferred. Only 183 women (28.5%) underwent prenatal diagnosis, resulting in 209 karyotypes with seven (3.3%) chromosome aberrations. Six major chromosomal abnormalities (2.9%) and one inherited structural chromosome aberration (0.5%) were found, but no sex chromosome aberrations. The frequency of multiple birth, Caesarean section rate, gestational age, preterm birth, and birth weight were comparable with previous studies. The perinatal mortality rate was 13.7 per 1000 children born with a gestational age of 24 weeks or more. In 2.2% (n = 16) of the liveborn infants, and in 2.7% (n = 20) of all infants, major birth defects were reported by the parents. Minor birth defects were found in nine liveborn infants (1.2%). In conclusion, the results of this study on outcome of ICSI pregnancies are in line with earlier reports, except that no sex chromosome abnormalities were found.

Entities:  

Mesh:

Year:  1999        PMID: 10438441     DOI: 10.1093/humrep/14.8.2143

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Intracytoplasmic sperm injection and other aspects of new reproductive technologies.

Authors:  A G Sutcliffe
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

2.  A prospective randomized trial of conventional in vitro fertilization versus intracytoplasmic sperm injection in unexplained infertility.

Authors:  Shu C Foong; Judy A Fleetham; Joseph A O'Keane; Selma G Scott; Suzanne C Tough; Calvin A Greene
Journal:  J Assist Reprod Genet       Date:  2006-04-19       Impact factor: 3.412

Review 3.  Intracytoplasmic sperm injection (ICSI)--what are the risks?

Authors:  Joseph P Alukal; Dolores J Lamb
Journal:  Urol Clin North Am       Date:  2008-05       Impact factor: 2.241

4.  Comparison of embryo quality between intracytoplasmic sperm injection and in vitro fertilization in sibling oocytes.

Authors:  R Yoeli; R Orvieto; J Ashkenazi; M Shelef; Z Ben-Rafael; I Bar-Hava
Journal:  J Assist Reprod Genet       Date:  2008-01-19       Impact factor: 3.412

Review 5.  A benefit-risk assessment of medical treatment for uterine leiomyomas.

Authors:  Vincenzo De Leo; Giuseppe Morgante; Antonio La Marca; Maria Concetta Musacchio; Massimo Sorace; Chiara Cavicchioli; Felice Petraglia
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  High sex chromosome aneuploidy and diploidy rate of epididymal spermatozoa in obstructive azoospermic men.

Authors:  Nares Sukcharoen; Jiraporn Ngeamvijawat; Tippawan Sithipravej; Sakchai Promviengchai
Journal:  J Assist Reprod Genet       Date:  2003-05       Impact factor: 3.412

Review 7.  Is intracytoplasmic sperm injection safe? Current status and future concerns.

Authors:  D M Nudell; L I Lipshultz
Journal:  Curr Urol Rep       Date:  2001-12       Impact factor: 3.092

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.